Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac ion-channel proteins are pore-forming membrane proteins that regulate the passive flow of ions (such as Na⁺, K⁺, Ca²⁺, and Cl⁻) across the cardiac cell membrane. These channels are essential for generating and propagating the cardiac action potential, which underlies rhythmic contraction and relaxation of heart muscle. The selective permeability and dynamic gating properties of these channels enable precise control over cardiac excitability and contractility. Disruption due to genetic mutations can cause arrhythmias such as Long QT Syndrome (LQTS), Brugada syndrome, etc., often via altered gating/repolarization properties leading to abnormal rhythms and risk of sudden death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac Ion-Channel Proteins.